Market revenue in 2023 | USD 507.7 million |
Market revenue in 2030 | USD 946.8 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.77% in 2023. Horizon Databook has segmented the Belgium home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Bank Group, the country’s population aged 65 & above accounted for nearly 18.6% of the total population in 2017 and around 19.0% in 2019. Rise in geriatric population is anticipated to increase the demand for long-term and home care services, thereby boosting the market growth. Nearly 23.5% of its population is expected to be aged above 65 by 2030, thus, Belgium is also projected to be among the super-aged countries, which is expected to fuel the market growth.
In addition, home nursing in the country is funded by federal authorities and depending on the type of service, it is either a fee-for-service or lump-sum payment. The lump-sum payment is for services provided to patients having difficulty performing daily life activities, while the fee-for service payment option covers services that mandate a physician’s prescription. Availability of such home nursing funding options along with funding from the central government bodies for home care is anticipated to increase the adoption of home infusion services.
Horizon Databook provides a detailed overview of country-level data and insights on the Belgium home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Belgium home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account